Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,161.2
-5.7 (-0.18%)

 

  • STI Straits Times Index
    3,161.2
    -5.7 (-0.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,493.0
    -1.6 (-0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,235.8
    274.8 (1.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,464.3
    66.9 (1.97%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,781.0
    497.4 (1.82%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,096.5
    26.5 (0.44%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,145.9M
  • Value: 1,099.4M
  • Rise: 166
  • Fall: 177
  • Unch: 418

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.116+0.001
Rex Intl0.235+0.025
Abundance Intl0.046+0.004
Raffles Edu0.080-0.020
Genting Sing0.805-0.005
Mercurius0.057-0.004
KTL Global^0.122+0.004
YZJ Shipbldg SGD1.390+0.020
ISDN0.810+0.045
ThaiBev0.645-0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,672.7 -105.6
HSI 26,235.8 +274.8
HSCEI 9,336.6 +103.4
Jakarta 6,096.5 +26.5
Nikkei 225 27,781.0 +497.4
SSE Comp 3,464.3 +66.9
Shanghai A 3,630.9 +70.2
Shanghai B 257.6 +3.6
KOSPI 3,223.0 +20.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Yunnan Energy YUNNAN ENERGY INTL CO. LIMITED
Quotes 10 Minutes Delayed. Updated at 02 Aug 2021 07:12
Last (SGD): 0.169 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.169
Buy Price 0.140 Sell Price -
Buy Volume ('000) 50.0 Sell Volume ('000) -
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.03850 Trailing EPS (SGD) e -0.03850 NAV (SGD) b 0.1340
PE a - Trailing PE f - Price / NAV b 1.2612
Dividend (SGD) d - Cash In Hand (SGD) g - Issued & Paid-up Shares c 275,437,000
Dividend Yield (%) d - Price / Cash In Hand g - Treasury Shares h -
Beta - 75 Daysi -2.419 R-Squared - 75 Days(%)i 4.96 Market Cap (M) 46.549
Beta - 500 Daysi -0.399 R-Squared - 500 Days (%)i 0.79 Enterprise Value (M) 32.085
Piotroski F Score 2 Exchange Code T43 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 115.8303 6-Month VWAP 0.102 Free Float (%) 27.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Wholesale and Retail Trade - Medical Specialties
Category Classification China
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Jul 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Yunnan Energy SGX 46.549 - - 1.2612 -
Industry China SGX 771.488 24.504 32.908 0.7565 3.365
Medical Specialties SGX 1,832.353 14.126 3.644 4.1807 3.196
Local Peer Top Glove SGX 10,085.809 16.612 3.613 4.5868 3.105
Local Peer Medtecs Intl SGX 437.129 2.510 2.510 1.7090 8.434
Local Peer UGHealthcare SGX 338.942 25.287 5.022 2.6686 0.413
Local Peer Biolidics SGX 69.018 - - 8.3333 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer ABBOTT LABORATORIES NYSE 214,959.684 48.057 33.847 - 1.261
Global Peer DANAHER CORP NYSE 212,378.111 60.507 60.507 5.3783 0.241
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 212,239.050 33.292 24.690 5.7589 0.164
Global Peer MEDTRONIC PLC NYSE 176,467.509 48.937 48.937 3.4314 1.769
Global Peer INTUITIVE SURGICAL INC NASDAQ 117,733.892 111.007 72.559 10.8636 -
Global Peer STRYKER CORP NYSE 102,170.390 63.896 49.050 7.3929 0.867
Global Peer BECTON DICKINSON & CO NYSE 74,376.959 96.971 45.352 2.9962 1.232
Global Peer EDWARDS LIFESCIENCES CORP NYSE 69,791.186 84.760 71.735 - -
Global Peer BOSTON SCIENTIFIC CORP NYSE 64,793.496 - 138.448 - -
Global Peer IDEXX LABORATORIES INC NASDAQ 57,865.513 99.463 85.828 82.3479 -
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), RESMED INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), NOVOCURE LTD (NASDAQ), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), MICROPORT-100 (HKEx), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), ANGELALIGN (HKEx), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), ENVISTA HOLDINGS CORPORATION (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), QUIDEL CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), HARTA (Bursa), NEVRO CORP (NYSE), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), INMODE LTD (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), EBOS GROUP (ASX), CARDIOFLOW-B (HKEx), NUVASIVE INC (NASDAQ), HAEMONETICS CORP (NYSE), AXONICS INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), VENUS MEDTECH-B (HKEx), PEIJIA-B (HKEx), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), GLAUKOS CORPORATION (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), LIFETECH SCI (HKEx), ZYLOXTB-B (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), SUPERMX (Bursa), BIOLIFE SOLUTIONS INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), INOGEN INC (NASDAQ), KANGJI MEDICAL (HKEx), BUTTERFLY NETWORK INC (NYSE), LANTHEUS HOLDINGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), EARGO INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), AK MEDICAL (HKEx), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), NANOSONICS LIMITED (ASX), LEMAITRE VASCULAR INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), VIEWRAY INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CRYOLIFE INC (NYSE), ANGIODYNAMICS INC (NASDAQ), SI BONE INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CHUNLI MEDICAL (HKEx), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), BIOVENTUS INC (NASDAQ), CERUS CORP (NASDAQ), 908 DEVICES INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), AXOGEN INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), MODERN DENTAL (HKEx), TRANSMEDICS GROUP INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), KDL MEDICAL (HKEx), STEREOTAXIS INC (NYSE American), VAPOTHERM INC (NYSE), BASECARE-B (HKEx), PAVMED INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), NEUROPACE INC (NASDAQ), ZYNEX INC (NASDAQ), SIENTRA INC (NASDAQ), SOLITON INC (NASDAQ), ONCOCYTE CORP (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), IRADIMED CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), LUCIRA HEALTH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CVRX INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), NEURONETICS INC (NASDAQ), YESTAR HEALTH (HKEx), CYTOSORBENTS CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), INVACARE CORP (NYSE), DARIOHEALTH CORP (NASDAQ), CORMEDIX INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), INTRICOM CORP (NASDAQ), TELA BIO INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), TITAN MEDICAL INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), ALPHA PRO TECH (NYSE American), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), CHECK-CAP LTD (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), MICRO-X LTD (ASX), IRIDEX CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), OPTISCAN IMAGING (ASX), AVINGER INC (NASDAQ), LENSAR INC (NASDAQ), BIOLASE INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), NEUROMETRIX INC (NASDAQ), NEPHROS INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), SDI LTD (ASX), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), ADVENTA (Bursa), YUNNAN ENERGY (HKEx), SENSUS HEALTHCARE INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), NEOVASC INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), RGTBHD (Bursa), HANCOCK JAFFE LABORATORIES INC (NASDAQ), COMPUMEDICS (ASX), CARDIEX LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), LKL (Bursa), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), ADHERIUM LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), METALICITY LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE American), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months -+0.101
+148.53 %
6 Months -+0.110
+186.44 %
1 Year -+0.010
+6.29 %
Long Term Return 2 Years -+0.073
+76.04 %
3 Years --0.356
-67.81 %
5 Years --0.071
-29.58 %
Annualised Return Annualised --
-6.77 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.059 - 0.169 Change From 1 Year Low +0.110 % Change From 1 Year Low (%) +186.44
Change From 1 Year High - % Change From 1 Year High (%) -
2 Years Range 0.059 - 0.169 Change From 2 Years Low +0.110 % Change From 2 Years Low (%) +186.44
Change From 2 Years High - % Change From 2 Years High (%) -
5 Years Range 0.059 - 0.695 Change From 5 Years Low +0.110 % Change From 5 Years Low (%) +186.44
Change From 5 Years High -0.526 % Change From 5 Years High (%) -75.68
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company was incorporated in Bermuda on 26 January 2004 under the name of Techcomp (Holdings) Limited. The Group is principally engaged in the design, development, manufacture and distribution of analytical instruments, life science equipment and laboratory instruments. It designs and manufactures various instruments, including gas and ion chromatographs, UV-Vis spectrophotometers and centrifuges for its house brand "Techcomp". The Group also manufactures for Hitachi High-Technologies Corporation on an original design manufacture ("ODM") basis. The Group’s manufacturing and distribution products address the academic, industrial, pharmaceutical, biotechnology and other research and laboratory markets, as well as the clinical laboratory and healthcare industries, agricultural and environmental industries, and government agencies. The Group’s products are used in industries and government agencies which conduct identification, quantification, material preparation and analysis of the elemental, molecular, physical, or biological composition or structure of liquids, solids, or gases. The Group has manufacturing operations in Shanghai and Tianjin. It has various technological partnerships and alliances, including agreements with Hitachi Naka Instrument Co Ltd for the development of UV-Vis spectrophotometers, Hitachi Koki Co Ltd for the development of centrifuges, and Alltech for the development of chromatographs.The Group distributes analytical instruments, life science equipment and laboratory instruments to customers in China, Hong Kong, Japan, Europe, the United States, Southeast Asia, South Asia and Australia through its trading subsidiaries located in Tianjin, Shanghai, Guangzhou, Hong Kong and Singapore, and its 11 liaison offices in China. Through its subsidiaries and third party distributors, it is also able to offer its customers maintenance and application support and repair services for all the products manufactured and distributed.

To more accurately reflect the Group’s current business activities and direction of future development, the company has changed its name from “Techcomp (Holdings) Limited” to “Yunnan Energy International Co. Limited”. Trading under new name with effect from 12 Dec 2018.

IPO Performance

Listing Date 12 Jul 2004 Full Subscription Rate (x) 5.42
No of Placement Shares (M) 37.00 No of Public Offer Shares (M) 3.00 Public Offer Subscription Rate (x) 59.90
IPO Price (SGD) a 0.267 First Day Close (SGD) a 0.290 First Week Close (SGD) a 0.253
Current vs IPO Price (%) -36.70 First Day Gain (%) +8.61 First Week Gain (%) -5.24
Notes:
  1. Adjusted for the following: Bonus Issue 1 for 2 on 04/05/2010

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2020 Dec 2020 Part 1(1.19 MB)
Part 2(1.37 MB)
Part 3(0.66 MB)
Part 4(0.91 MB)
Annual Report 2019 Dec 2019 Part 1(6.54 MB)
Part 2(6.60 MB)
Part 3(0.28 MB)
Part 4(0.50 MB)
Annual Report 2018 Dec 2018 Part 1(1.26 MB)
Part 2(1.42 MB)
Part 3(0.29 MB)
Part 4(0.51 MB)
Annual Report 2017 Dec 2017 Part 1(5.92 MB)
Part 2(6.03 MB)
Part 3(0.10 MB)
Part 4(0.20 MB)
Annual Report 2016 Dec 2016 Part 1(4.85 MB)
Part 2(0.10 MB)
Part 3(4.15 MB)
Part 4(0.21 MB)
Annual Report 2015 Dec 2015 Part 1(2.46 MB)
Part 2(0.10 MB)
Part 3(2.98 MB)
Part 4(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(1.72 MB)
Annual Report 2013 Dec 2013 Part 1(4.97 MB)
Part 2(0.05 MB)
Part 3(0.13 MB)
Annual Report 2012 Dec 2012 Part 1(1.04 MB)
Annual Report 2011 Dec 2011 Part 1(1.21 MB)
Annual Report 2010 Dec 2010 Part 1(0.91 MB)
Annual Report 2009 Dec 2009 Part 1(3.10 MB)
Annual Report 2008 Dec 2008 Part 1(1.76 MB)
Annual Report 2007 Dec 2007 Part 1(1.33 MB)
Annual Report 2006 Dec 2006 Part 1(1.05 MB)
Annual Report 2005 Dec 2005 Part 1(1.25 MB)
Interim Report
Interim Report 2020 Jun 2020 Part 1(0.53 MB)
Part 2(1.18 MB)
Interim Report 2019 Jun 2019 Part 1(0.77 MB)
Part 2(1.41 MB)
Interim Report 2018 Jun 2018 Part 1(1.65 MB)
Part 2(1.08 MB)
Interim Report 2017 Jun 2017 Part 1(0.88 MB)
Part 2(1.38 MB)
Interim Report 2016 Jun 2016 Part 1(0.18 MB)
Part 2(0.62 MB)
Interim Report 2015 Jun 2015 Part 1(0.49 MB)
Part 2(1.44 MB)
Interim Report 2014 Jun 2014 Part 1(0.22 MB)
Part 2(0.72 MB)
Interim Report 2013 Jun 2013 Part 1(1.02 MB)
Interim Report 2012 Jun 2012 Part 1(0.16 MB)
IPO Prospectus
IPO Prospectus 2004 Jul 2004 Part 1(2.46 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
02 Aug 2021 0.169 0.169 0.169 0.169 - -
30 Jul 2021 0.169 0.169 0.169 0.169 - -
29 Jul 2021 0.169 0.169 0.169 0.169 - -
28 Jul 2021 0.169 0.169 0.169 0.169 - -
27 Jul 2021 0.169 0.169 0.169 0.169 - -
26 Jul 2021 0.169 0.169 0.169 0.169 - -
23 Jul 2021 0.169 0.169 0.169 0.169 - -
22 Jul 2021 0.169 0.169 0.169 0.169 - -
21 Jul 2021 0.169 0.169 0.169 0.169 - -
19 Jul 2021 0.169 0.169 0.169 0.169 - -
16 Jul 2021 0.169 0.169 0.169 0.169 - -
15 Jul 2021 0.169 0.169 0.169 0.169 - -
14 Jul 2021 0.169 0.169 0.169 0.169 - -
13 Jul 2021 0.169 0.169 0.169 0.169 - -
12 Jul 2021 0.169 0.169 0.169 0.169 - -
09 Jul 2021 0.169 0.169 0.169 0.169 - -
08 Jul 2021 0.169 0.169 0.169 0.169 - -
07 Jul 2021 0.169 0.169 0.169 0.169 - -
06 Jul 2021 0.169 0.169 0.169 0.169 - -
05 Jul 2021 0.169 0.169 0.169 0.169 - -
02 Jul 2021 0.169 0.169 0.169 0.169 - -
01 Jul 2021 0.169 0.169 0.169 0.169 - -
Summary
Current 2 Weeks
(19 Jul 2021 to 02 Aug 2021)
0.169 0.169 0.169 0.169 - -
Previous 2 Weeks
(05 Jul 2021 to 16 Jul 2021)
0.169 0.169 0.169 0.169 - -
4 Weeks from
(07 Jun 2021 to 02 Jul 2021)
0.150 0.169 0.150 0.169 10,000 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.